Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2010

View Archived Issues

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Tasocitinib shows promising pharmacokinetics in ocular tissues

Vertex Pharmaceuticals patents new protein kinase C inhibitors

New ligands of nicotinic acetylcholine receptor alpha 7 disclosed by NeuroSearch

Treatment complete in phase II trial of fasitibant in osteoarthritis

Lilly suspends phase III trial of tasisulam in metastatic melanoma

Merck Frosst identifies potent 5-LO inhibitor MK-5286

CCX-721 has antitumor effects in murine model of multiple myeloma

Scientists identify new genetic link to risk of psoriasis

Angelica Therapeutics receives grant for anticancer candidate angeloxin

Orexo's new sublingual tablet formulation of buprenorphine/naloxone completes phase I trial

New PI3K-delta/gamma inhibitors discovered at Cellzome

Santen launches Diquas in Japan for dry eye syndrome

Bepotastine besilate nasal spray advances into phase II trial in allergic rhinitis

New inhibitors of fatty-acid amide hydrolase 1 claimed

Preliminary phase Ib/IIa data presented on ibudilast in opioid addiction

Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment

FDA approves Prezista/ritonavir q.d. for treatment-experienced adults with HIV and no DRV RAMs

Lexicon Pharma reports phase IIa data on LX-2931 in rheumatoid arthritis

New inhibitors claimed of mitochondrial cytochrome P450 11B1/2

Anaphore and Mitsubishi Tanabe Pharma to develop protein therapies for autoimmune disorders

PATH MVI, Merck & Co. and NYU Langone Medical Center to develop malaria vaccine

MHRA accepts BioMarin's application for phase III GALNS trial in MPS IVA

Neurokine completes trial plan for etanercept in Alzheimer's-type memory loss after CABG surgery

Novartis to take full ownership of Alcon

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...